3 ms·
The issue with Astrazeneca is that they messed up part of their clinical trials. The results weren’t even negative. A subset of their trial group received a di
by geuis 6y ago
The issue with Astrazeneca is that they messed up part of their clinical trials.
The results weren’t even negative. A subset of their trial group received a different amount of vaccine which seemed to show greater efficacy later.
The issue, and thus the “mistrust”, is that if they messed up that rather critical part of their clinical trials then what else could they have messed up?